A recall of heart and blood pressure medication for possible carcinogen gets expanded

Teva Pharmaceuticals’ April recall of blood pressure and heart medication losartan has been expanded by six bulk lots after the possibly cancerous impurity NMBA was found in the active ingredient. … Click to Continue »

View original article